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hnRNP CAs a conserved non-coding RNA gene, transcripts of MALAT-1 localize predominately in the nucleus.
However in G2/M cell cycle phase, MALAT-1 transcripts were surprisingly found to translocate from
the nucleus into the cytoplasm. Investigation also found that in this process MALAT-1 interacts with
an abundant nuclear factor, hnRNP C protein. Using a loss-of-function assay, we found that down-
regulation of MALAT-1 expression compromised the cytoplasmic translocation of hnRNP C in the G2/
M phase and resulted in G2/M arrest. In addition to characterize the physiological interaction
between MALAT-1 and hnRNP C, our study also highlights the role of MALAT-1 in cell cycle
regulation.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Recent genome-wide studies revealed that most of the human
and mouse genomes are transcribed to yield thousands of long
non-coding RNAs with little or no protein-coding potential [1,2].
Long non-coding RNAs are mRNA-like RNA transcripts ranging
from 200 nt to >100 knt in size. Even though many of them exhibit
cell-type-speciﬁc expression proﬁles [3] and have been implicated
in many essential cellular activities including proliferation and dif-
ferentiation [4], mechanistic evidence supporting their physiologi-
cal functions is still absent for them.
Among these, MALAT-1 (metastasis-associated lung adenocar-
cinoma transcript 1) is a long non-coding RNA species distributed
mainly in the nucleus. It was ﬁrst found in non-small cell lung tu-
mors and then in many cancer types [5–7]. In addition to cancer
tissues, high expression levels of MALAT-1 have been reported in
a number of normal tissues, including brain [8]. The transcripts
of MALAT-1 are localized mainly in nuclear speckles and function
in pre-mRNA splicing by modulating SR splicing factor [9]. In cul-
tured hippocampal neurons, MALAT-1 modulates synaptogenesis
[8]. Down-regulating its expression decreases synaptic density
and up-regulating its expression increases cell-autonomous syna-
ptogenesis [8]. More recently, it was reported that MALAT-1 inter-
acts with unmethylated polycomb 2 protein to activate the
growth-control program. Silencing MALAT-1 expression in HeLa
cells causes the loss of serum-stimulated cell proliferation andprofound G1/S arrest [10]. However, by modulating the level of
pre-mRNA splicing factor and the phosphorylation status of several
SR family splicing factors, Tripathi and colleagues found G2/M ar-
rest and increased cell death in MALAT1-depleted HeLa cells [9].
This recent evidence suggests that MALAT-1 might play a role in
cell cycle regulation.
Heterogeneous nuclear ribonucleoprotein C (hnRNP C) is one of
the most abundant nuclear proteins essential for mRNA metabo-
lism, cell proliferation and differentiation [11,12]. Previous studies
showed that HnRNP C translocates from the nucleus to the cyto-
plasm in the G2/M phase to increase the IRES-dependent transla-
tion of c-myc [13,14]. Supporting these ﬁndings, another study
also reported that hnRNP C regulates IRES-mediated translation
in G2/M phase and found that this translocation is indispensable
for cells to progress through the G2/M phase [15]. Even so, it is
not clear how hnRNP C protein translocates from the nucleus to
the cytoplasm to function in regulating mitosis.
To elucidate the potential activities of MALAT-1 in cell cycle
regulation, we ﬁrst examined the distribution of MALAT-1 tran-
scripts in different phases of the cycle, and surprisingly found that
the transcripts partially translocated from the nucleus to the cyto-
plasm in G2/M phase. Further investigation showed that MALAT-1
interacted with hnRNP C in the cytoplasm, and this was of critical
importance to the cytoplasmic translocation of hnRNP C. Down-
regulating the expression of MALAT-1 not only compromised the
translocation of hnRNP C in G2/M phase, but also led to G2/M ar-
rest in cultured cells. This evidence therefore integrates long
non-coding MALAT-1 into an established cell cycling network
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tial role of MALAT-1 in cell cycle regulation.
2. Materials and methods
2.1. Cell culture and synchronization
HepG2 and HeLa cell lines were purchased from ATCC and
grown in DMEM supplemented with 10% fetal calf serum and 1%
penicillin/streptomycin at 37 C under 5% CO2. For cell-cycle syn-
chronization, the procedure described by Yang et al. [16] was used.
A double thymidine block was performed to obtain cell popula-
tions in S phase, and Thymidine-nocodazole block was performed
to obtain cell populations in G1 and M phase. The cells were syn-
chronized at the G2/M boundary by a double-thymidine block, re-
leased for 6 h, and then exposed to nocodazole (100 ng/ml).
2.2. Immunoﬂuorescence staining
Immunolocalization of proteins was performed as described
previously [17]. Brieﬂy, cells were ﬁxed in 2% formaldehyde for
15 min at room temperature and permeabilized in 0.5% Triton X-
100/PBS for 10 min on ice. Cells were incubated with primary
and secondary antibodies in a humidiﬁed chamber, and ﬁnally
stained with DAPI and mounted using PPD. The immunoﬂuores-
cence was visualized using a ﬂuorescence microscope.
2.3. RNA and protein isolation
Isolation of cytoplasmic or nuclear RNAs and proteins was per-
formed using the PARIS™ kit (Ambion) and the NE-PER kit (Ther-
mo). After RNA isolation, cDNA was synthesized with SuperScript
II (Invitrogen) and qPCR assays were performed using SYBR Green
A PCR mix. Relative expression values were calculated (DDCT
method), using GAPDH or 18s RNA as an internal control.
For protein fractionation, the cells were harvested by trypsin–
EDTA digestion and centrifugation. Cytoplasmic and nuclear pro-
tein fractions were then obtained using NE-PER protein extraction
kit (Thermo Scientiﬁc), following the manufacturer’s
recommendations.
2.4. Gene cloning and RNA pull-down
Fragments of MALAT-1 were sub-cloned from the full-length
cDNA sequence. For RNA pull-down, MALAT-1 fragments were la-
beled with biotin by T7 RNA polymerase-mediated transcription.
Five picomoles of biotinylated RNA was incubated with pre-
blocked Streptavidin agarose beads (Invitrogen) at 4 C for 5 h, fol-
lowed by extensive washes to obtain biotinylated RNA-conjugated
agarose beads. Then, 200 lg of splicing-competent HepG2 cell ex-
tract was added and incubated for 1 h at 30 C, with slow rotation.
To extract MALAT-1-interacting proteins, the beads were washed
and boiled in SDS buffer, and the retrieved protein was analyzed
by 20% SDS–PAGE and silver staining.
2.5. Protein characterization by MS
Protein bands were digested in gel by trypsin. Extracted pep-
tides were loaded onto a C18 reverse-phase column with a pulled
tip (100 lm ID; 8 cm in length), packed with 3-lm, 125-Å Aqua
C18 resin (Phenomenex). LC–MS/MS analysis was performed over
a 66-min run on an LTQ-Orbitrap mass spectrometer (Thermo-
Fisher Scientiﬁc) connected to an Agilent 1200 quaternary HPLC
Pump.2.6. RNA Immunoprecipitation
A modiﬁed Nature protocol [18] was performed in RIP. One mil-
liliter of Trizol (Invitrogen) was added to the beads to extract pro-
tein-interacting RNA, which was then treated with RNase-free
DNase I (NEB) and measured by RT-PCR assay.
2.7. siRNA transfection and ﬂow cytometry assay
Chemically synthesized siRNAs (Supplementary Table 2) were
transfected into cultured cells using Lipofectamine 2000 (Invitro-
gen). Harvest the cells after 48 h and detect the gene silencing
effect.
For the ﬂow cytometry assay, the procedure described by Yang
et al. [16]. Cell cycle proﬁles were assessed by a BD Biosciences
FACScan with MODFIT software. At least 10000 cells in each sam-
ple were analyzed to obtain a measurable signal, using the same
instrument setting.
2.8. Rescue assay
HnRNP C cDNA was PCR ampliﬁed from total RNA, digested
with Xhol and Hindlll, and cloned into pcDNA3.1 expression vector.
The fusion or control vectors were then transfected into Hela cells
with MALAT-1-targeting siRNA. FACS assays were performed 48 h
after transfection.
2.9. Cell proliferation assay
Asynchronously growing Hela cells were transfected with MA-
LAT-1-targeting siRNAs and an irrelevant siRNA control. After
transfection, the numbers of the cells was counted at 0 h, 24 h,
48 h, 72 h and 96 h. Then, a growth curve was plotted to examine
the effects of the siRNAs on cell proliferation. The experiments
were repeated for three times.
3. Results
3.1. MALAT-1 translocates from the nucleus to the cytoplasm in G2/M
phase
MALAT-1 transcripts are localized predominantly in nuclear
speckles. However, when we proﬁled their distribution throughout
the cell cycle, we were surprised to ﬁnd that they partially translo-
cated from the nucleus to the cytoplasm in the G2/M phase in syn-
chronized HeLa cells, which was in sharp contrast to the
unsynchronized cell populations (Fig. 1A). To conﬁrm this observa-
tion, the change of cytoplasmic levels of MALAT-1 in G2/M was
determined using quantitative RT-PCR. This revealed a more than
4-fold increase of cytoplasmic MALAT-1 in G2/M-synchronized
cells, in contrast to the comparable total MALAT-1 levels in syn-
chronized and unsynchronized cell populations (Fig. 1B). Addition-
ally, analysis of the nuclear/cytoplasmic distribution of MALAT-1
during the cell cycle presented a distinct proﬁle, showing a pro-
found enrichment in cytoplasm in G2/M phase (Supplementary
Fig. 1).
The synchronization was performed by thymidine-nocodazole
block, and the separation of nuclear and cytoplasmic fractions
were made using a commercial kit. To conﬁrm the synchronization
of the cells, FACS assays were performed to show that more than
90% of the cells are in G2/M cell cycle phase; and cyclin B1, a char-
acterized G2/M marker was shown highly expressed in the syn-
chronized cells (Fig. 1C). To further conﬁrm the integrity of the
nuclear membranes, immuno-staining of a nuclear membrane
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Fig. 1. Translocation of MALAT-1 RNAs from nucleus to cytoplasm in G2/M cell cycle phase. (A) The sub-cellular localization of MALAT-1 transcripts is detected at G2/M phase
in Hela cells. Cytoplasmic and nuclear RNAs are isolated from unsynchronized (CTR) and synchronized (G2/M) cells, and their levels are analyzed by RT-PCR. 7S RNA and U6
RNA are included as cytoplasmic and nuclear markers. N, nuclear RNA; C, cytoplasmic RNA. (B) The levels of MALAT-1 are quantiﬁed by qRT-PCR in RNA samples extracted
from synchronized (G2/M) and unsynchronized (CTR) Hela cells. 18S rRNA is included as an internal control and the results are normalized to CTR and presented as
mean ± S.D. (n = 3). T, total RNA; N, nuclear RNA; C, cytoplasmic RNA. (C) Up panel: HeLa cells are synchronized in G2/M phase by thymidine-nocodazole treatment, and the
cell cycle proﬁles are determined by propidium iodide (PI) staining and ﬂow cytometry assay. Low panel: the levels of Cyclin B1 and GAPDH are determined in cell extracts
from unsynchronized (CTR) and synchronized (G2/M) cell populations, using Western blot assay. (D) Cells in G2/M phase were immunostained for nuclear envelope marker
LaminA/C (green ﬂuorescence), using an Alexa-conjugated secondary antibody. The nuclei were counterstained with DAPI (blue ﬂuorescence). Red arrow, M-phase cells;
white arrow, G2 phase cells.
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clear membrane for majority of the isolated cells. The successful
separation of the nuclear and cytoplasm components was demon-
strated by RT-PCR assays, using a nuclear-localized U6 RNA and a
cytoplasm-localized 7S RNA as the controls (Fig. 1A).
3.2. Interaction between MALAT-1 and hnRNP C
Long non-coding RNAs are transcripts with little or no protein-
coding potential [19]. Multiple studies have reported that they
may function through interacting with protein factors [10,20–22].
To explore the biological importance of the nuclear-cytoplasmic
translocation of MALAT-1, RNA pull-down assay was ﬁrst carried
out to characterize potential MALAT-1-interacting proteins during
the process. To this end, biotin-labeled and unlabeled fragments of
MALAT-1 RNA were synthesized by in vitro transcription and
incubated with cell extracts, so as to conjugate with potential
MALAT-1-interacting proteins. The RNA–protein complexes were
then isolated using streptavidin-coated Sepharose, and resolved
in an SDS–PAGE gel (Fig. 2A). A differentially presented protein
band was isolated from the biotin-labeled RNA–protein complex,
and its protein components were characterized by mass spectrom-
etry assay (MS). In total, 18 independent proteins were identiﬁed
(Supplementary Table 1) and six of them have RNA-binding do-
mains (Table 1). Among these, hnRNP C protein was of particular
interest due to its RNA-binding capability and the reported
cytoplasmic translocation in the G2/M phase.
To demonstrate the interaction between hnRNP C and MALAT-
1, a systematic RNA pull-down assay was performed. Using multi-
ple biotinylated RNA fragments covering the whole MALAT-1transcript, interacting-proteins were isolated and among them,
the presence of hnRNP C was demonstrated by Western blot
(Fig. 2B). Compared to the insufﬁcient binding capacity at the 50
end of the transcript, strong binding to hnRNP C was shown for
the other parts of MALAT-1.
To further characterize the in vivo interaction between MALAT-
1 and hnRNP C, cell-based RNA immunoprecipitation (RIP) assays
were carried out in HeLa cells. Using anti-hnRNP C antibody,
hnRNP C-conjugated RNAs were isolated and among them, the
presence of MALAT-1 was determined by gene-speciﬁc RT-PCR
(Fig. 2C). Taken together, these lines of evidence demonstrated a
physiological interaction between MALAT-1 and hnRNP C.
3.3. Silencing MALAT-1 expression compromised the translocation of
hnRNP C
Previous studies indicated that hnRNP C protein translocated
from the nucleus to the cytoplasm in G2/M phase, enhancing
IRES-mediated translation and leading to mitosis regulation
[13,15]. To conﬁrm these observations in our system, cytoplasmic
and nuclear proteins were isolated from synchronized and un-syn-
chronized HeLa cells, the distribution of hnRNP C protein was then
investigated by Western blot. In agreement with earlier studies
[13,15], our results showed that hnRNP C partially translocated
from the nucleus to the cytoplasm in G2/M-phase-synchronized
cells (Fig. 3A). Compared to unsynchronized cell populations, a sig-
niﬁcant increase of cytoplasmic hnRNP C level was identiﬁed. This
is in sharp contrast to the distribution of Lamin A/C and GAPDH,
which are known localized predominately in the nucleus or the
cytoplasm (Fig. 3A). To further demonstrate the MALAT-1-hnRNP
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Fig. 2. Interaction of MALAT-1 and hnRNP C in vitro and in vivo. (A) Identiﬁcation of MALAT-1-interacting proteins. Biotin-labeled MALAT-1 probes are used to isolate
MALAT-1-interacting proteins, which are then resolved in SDS–PAGE and visualized by silver staining. A differentially presented band indicated by arrow is picked for
component proteins identiﬁcation by nanoLC-LTQ-Orbitrap-MS/MS assay. MALAT-1 probe 1, position 2282–4490 nt along MALAT-1 transcript; MALAT-1 probe 2, position
21–2382 nt along the transcript. L, biotin-labeled probe; N, unlabeled probe. (B) Characterization of the hnRNP C-interacting regions in MALAT-1 transcript. RNA fragments
corresponding to different regions in MALAT-1 transcript are labeled by biotin using in vitro transcription and used to isolate MALAT-1-interacting proteins; the presence of
hnRNP C is then assessed by Western blot using anti-hnRNP C antibody. (C) in vivo interaction of endogenous MALAT-1 and hnRNP C. RNA immunoprecipitation (RIP) is
performed with HepG2 cell extracts to enrich RNAs interacting with hnRNP C, GAPDH or hnRNP A2/B1 proteins, the presence of MALAT-1 RNA was determined by MALAT-1
speciﬁc RT-PCR.
Table 1
MALAT-1-interacting proteins identiﬁed by nanoLC-LTQ-Orbitrap-MS/MS.
Gene symbol Mass (Da) Gene name RNA binding domain Function
HNRNPC 34 Heterogeneous nuclear ribonucleoprotein C1/C2 Yes mRNA splicing and processing
HNRNPF 46 Heterogeneous nuclear ribonucleoprotein F Yes Alternative splicing
HNRNPH1 49 Heterogeneous nuclear ribonucleoprotein H1 Yes Alternative pre-mRNA splicing
HNRNPH2 49 Heterogeneous nuclear ribonucleoprotein H2 Yes Thymidine phosphorylase (TP) splicing
HNRNPUL1 96 Heterogeneous nuclear ribonucleoprotein U-like 1 Yes DNA damage; nucleocytoplasmic RNA transport
SS-B/La protein 47 Sjogren syndrome antigen B Yes Diverse aspects of RNA metabolism; enhancing translation
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phase-synchronized cells using anti-hnRNP C antibody. Among the
isolated hnRNP C-interacting RNAs, the presence of MALAT-1 tran-
scripts was validated by gene-speciﬁc RT-PCR, therefore demon-
strating the interaction of cytoplasmic MALAT-1 with hnRNP C in
G2/M-synchronized cells (Supplementary Fig. 2A). Anti-hnRNP
A2/B1 and anti-IgG antibodies were included in the assay as con-
trols, and showed no discernible MALAT-1 signal (Supplementary
Fig. 2A).
Taken these evidence together, we hypothesize that the demon-
strated interaction, as well as the cytoplasmic translocation of MA-
LAT-1 and hnRNP C, might be synergistic. To test this possibility,
siRNAs target MALAT-1 and hnRNP C were designed and their gene
silencing activities were assessed using qRT-PCR (Supplementary
Fig. 2B and C). By silencing the expression of MALAT-1, we found
that less hnRNP C protein translocated to the cytoplasm in G2/M
phase, in comparison to the irrelevant siRNA controls (Fig. 3B).
Accordingly, enrichment of hnRNP C was observed in the nucleus,
compared to the control. Western blot performed with totalproteins however showed that the total amount of hnRNP C pro-
tein was unchanged (Supplementary Fig. 2D), indicating that
silencing MALAT-1 expression compromised only the cytoplasmic
translocation but not the expression of hnRNP C.
3.4. MALAT-1 interacts with hnRNP C in cell cycle regulation
The co-translocation of MALAT-1 and hnRNP C in the G2/M
phase led us to speculate that MALAT-1 may play an essential role
in cell cycle regulation by interacting with hnRNP C. To test this
hypothesis, siRNAs targeting MALAT-1 or hnRNP C were individu-
ally transfected into HeLa cells, and cell cycle proﬁles were deter-
mined by PI staining and ﬂow cytometry assay, 48 h after cell
transfection. Compared to the control, down-regulation of hnRNP
C expression led to accumulation of the cells in G2/M phase
(Fig. 3C), which is consistent with previous reports [15]. Our study
further showed that down-regulating the MALAT-1 level also re-
sulted in enhanced accumulation in G2/M (Fig. 3C). More interest-
ingly, the gene-silencing activity of these siRNAs correlated very
AC
D
G1:65.34±1.46 
S:23.67±1.25
G2/M:10.99±0.60 
G1:56.65±2.02 
S:27.16±2.32
G2/M:16.19±0.40 
G1:64.05±2.42 
S:22.08±2.30
G2/M:14.24±0.39 
G1:44.46±2.91 
S:31.84±3.06
G2/M:23.70±0.37 
MALAT-1 siRNA1 NC hnRNP C siRNA1 
G1:49.30±2.20 
S:35.09±2.28
G2/M:15.61±1.38 
hnRNP C siRNA2 MALAT-1 siRNA2 
B
hnRNP C 
GAPDH 
Lamin A/C 
CTR  G2/M 
N            C N            C 
hnRNP C
Lamin A/C 
GAPDH 
    Nuclear Cytoplasmic 
1.00       1.33       1.21       1.00      0.73      0.83 
G1:56.49±1.01 
S:  32.57±1.11
G2/M:10.95±0.26 
G1:57.32±0.43 
S:  28.06±1.58
G2/M:14.63±1.39 
G1:56.87±3.09 
S:  29.6±2.47
G2/M:13.54±0.62 
pcDNA3.1+M-siRNA1 pcDNA3.1+NC
G1:59.41±1.55 
S: 29.44±1.27
G2/M:11.15±0.53 
pcDNA3.1+M-siRNA2 hnRNP C+M-siRNA2 
G1:57.79±1.29 
S:  31.49±1.77 
G2/M:10.73±0.49 
hnRNP C+M-siRNA1 
E
0D 1D 2D 3D 4D
0
5
10
15
20
NC
MALAT-1 siRNA1
MALAT-1 siRNA2
**
**
*
**
*
*
N
um
be
r o
f C
el
ls
 ×
10
5 F
PITSLREp58
GAPDH 
Fig. 3. Silencing the expression of MALAT-1 leads to compromised translocation of hnRNP C and G2/M arrest. (A) Translocation of hnRNP C from nucleus to cytoplasm in G2/
M phase. Cytoplasmic and nuclear proteins are isolated from unsynchronized (CTR) and synchronized (G2/M) cell populations. The levels of hnRNP C are determined by
Western blot using anti-hnRNP C1/C2 antibody. Lamin A/C and GAPDH are included as nucleus and cytoplasm marker proteins. N, nuclear proteins; C, cytoplasmic proteins.
(B) Silencing of MALAT-1 compromises the translocation of hnRNP C in G2/M phase. Nuclear proteins and cytoplasmic proteins are isolated from synchronized HeLa cells, in
which the expression of MALAT-1 is knocked-down by individual transfection of two siRNAs. The levels of hnRNP C are determined by Western blot using anti-hnRNP C1/C2
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these ﬁndings, rescue experiments were carried out by co-transfec-
tion of MALAT-1-targeting siRNA and hnRNP C over-expression
vector into Hela cells (Fig. 3D). Cell cycle proﬁling indicated that
over-expression of hnRNP C rescues the cells from G2/M arrest,
in comparison to the control assays. When Hela cells were treated
with MALAT-1 targeting siRNAs, their proliferation was signiﬁ-
cantly compromised (Fig. 3E). Down-regulation of MALAT-1 also
reduced the expression of PITSLREp58 gene (Fig. 3F), which is in
agreement with previous studies [15,23]. Taken together with ear-
lier data showing that down-regulation of MALAT-1 compromised
the cytoplasmic translocation of hnRNP C in G2/M phase, theselines of evidence demonstrated that long non-coding MALAT-1
functions in cell cycle regulation by facilitating the cytoplasmic
translocation of hnRNP C protein.
Based on these ﬁndings, a functional model was proposed to
integrate long non-coding RNA MALAT-1 into the established pro-
tein network in cell cycle regulation (Fig. 4). With this model, long
non-coding RNA interacts with protein factor hnRNP C in the nu-
cleus in interphase and when the cells progress into G2/M phase,
MALAT-1 facilitates the translocation of hnRNP C from the nucleus
to the cytoplasm, stimulates IRES-dependent translation, and
increases the levels of CDK11/PITSLREp58 protein in mitosis. The
CDK11/PITSLREp58 protein then functions in essential cell cycle
Interphase 
hnRNP C
 MALAT-1 
           hnRNP C  MALAT-1 
G2/M transition 
Nucleus 
 Cytoplasm 
    Mitosis 
hnRNP C PITSLREp58  mRNA 
Fig. 4. Association model of MALAT-1 and hnRNP C and its implications for cell cycle regulation. In interphase, MALAT-1 is associated with hnRNP C in the nucleus; and in the
G2/M phase, the MALAT-1-hnRNP C complex translocates to the cytoplasm, where hnRNP C regulates PITSLREp58 IRES-mediated translation. PITSLREp58 is essential for
centrosome maturation and bipolar mitotic spindle formation during mitosis.
3180 F. Yang et al. / FEBS Letters 587 (2013) 3175–3181regulation activity, including centrosome maturation and bipolar
mitotic spindle formation during mitosis phase [15,23]. When
the expression of MALAT-1 was knocked down, the cytoplasmic
translocation of hnRNP C was compromised, which may further
led to decreased CDK11/PITSLREp58 protein levels and G2/M arrest.
4. Discussion
MALAT-1 is an abundant long non-coding RNA enriched in the
nucleus, and it functions in many biological processes [24,25].
Using loss-of-function assays, studies showed that down-regula-
tion of its expression led to cell arrest in the G1/S or G2/M phase,
indicating that MALAT-1 may play an essential role in cell cycle
regulation [9,10]. In contrast to these in vitro studies, in vivo stud-
ies revealed that MALAT-1 depletion did not change the splicing
factors level and the phosphorylation status, or pre-mRNA splicing
pattern [26–28] in MALAT-1-KO mice, likely suggesting that MA-
LAT-1 is not an essential factor in mouse development. However,
more recent study found that depletion of MALAT-1 in cancer cells
did impaired its migration and led to less tumor nodules in a
mouse xenograft model [29].
Long non-coding RNAs function in many biological contexts and
most were found through their direct interactions with protein fac-
tors or their guidance of long non-coding RNA–protein complexes
to their target sites to regulate gene expression [20]. MALAT-1 is an
8-knt-long macromolecule that can form a complex structure to
recruit many different protein factors for functionality. In this
study, we showed that MALAT-1 interacted with hnRNP C and
facilitated its cytoplasmic translocation in the G2/M phase, thereby
regulating the progress of the cell cycle. The distinct cell
cycle-dependent translocation of MALAT-1 found in the study adds
another layer of complexity and diversity to the functional
mechanisms of long non-coding RNAs.
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